Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × Base Sequence × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Sarcoma 1 Rectal Neoplasms 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoblastic Lymphadenopathy 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1

Interventions

pembrolizumab 128 Gemcitabine 115 Capecitabine 107 Fluorouracil 99 Paclitaxel 98 Bevacizumab 91 Oxaliplatin 89 Nivolumab 84 Leucovorin 81 Docetaxel 77 Radiosurgery 74 Irinotecan 72 Cisplatin 69 Carboplatin 69 Cyclophosphamide 60 Magnetic Resonance Spectroscopy 59 Cetuximab 59 Biopsy 51 Specimen Handling 50 Trastuzumab 46 Radiotherapy 44 Ipilimumab 43 Pemetrexed 38 Everolimus 38 Drug Therapy 38 Albumin-Bound Paclitaxel 36 130-nm albumin-bound paclitaxel 36 Fulvestrant 34 Doxorubicin 34 aldesleukin 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡